{
  "pmid": "36449437",
  "uid": "36449437",
  "title": "Rivaroxaban in Rheumatic Heart Disease-Associated Atrial Fibrillation. Reply.",
  "abstract": "",
  "authors": [
    {
      "last_name": "Karthikeyan",
      "fore_name": "Ganesan",
      "initials": "G",
      "name": "Ganesan Karthikeyan",
      "affiliations": [
        "All India Institute of Medical Sciences, New Delhi, India."
      ]
    },
    {
      "last_name": "Connolly",
      "fore_name": "Stuart J",
      "initials": "SJ",
      "name": "Stuart J Connolly",
      "affiliations": [
        "Population Health Research Institute, Hamilton, ON, Canada connostu@phri.ca."
      ]
    },
    {
      "last_name": "Yusuf",
      "fore_name": "Salim",
      "initials": "S",
      "name": "Salim Yusuf",
      "affiliations": [
        "Population Health Research Institute, Hamilton, ON, Canada connostu@phri.ca."
      ]
    }
  ],
  "journal": {
    "title": "The New England journal of medicine",
    "iso_abbreviation": "N Engl J Med",
    "issn": "1533-4406",
    "issn_type": "Electronic",
    "volume": "387",
    "issue": "22",
    "pub_year": "2022",
    "pub_month": "Dec",
    "pub_day": "01"
  },
  "start_page": "2100",
  "end_page": "2101",
  "pages": "2100-2101",
  "language": "eng",
  "publication_types": [
    "Letter",
    "Comment"
  ],
  "keywords": [
    "Humans",
    "Rivaroxaban",
    "Atrial Fibrillation",
    "Rheumatic Heart Disease"
  ],
  "article_ids": {
    "pubmed": "36449437",
    "doi": "10.1056/NEJMc2213437",
    "pii": "10.1056/NEJMc2213437#sa3"
  },
  "doi": "10.1056/NEJMc2213437",
  "dates": {
    "completed": "2022-12-02",
    "revised": "2023-09-01"
  },
  "chemicals": [
    "Rivaroxaban"
  ],
  "grants": [],
  "search_metadata": {
    "search_type": "all_publications",
    "retrieved_date": "2025-07-30T15:11:43.111736",
    "pmid": "36449437"
  }
}